Synthesis and bioactivity of MSH4 oligomers prepared by an A2 + B2 strategy

Dilani Chathurika Dehigaspitiya, Suryakiran Navath, Craig S. Weber, Ronald M. Lynch, Eugene A. Mash

Research output: Contribution to journalArticlepeer-review

4 Scopus citations


Abstract Oligomers incorporating the tetrapeptide MSH4, the minimum active sequence of melanocyte stimulating hormone, were synthesized by an A2 + B2 strategy involving microwave-assisted copper-catalyzed azide-alkyne cycloaddition. A2 contained an MSH4 core while B2 contained a (Pro-Gly)3 spacer. Soluble mixtures containing compounds with up to eight MSH4 units were obtained from oligomerizations at high monomer concentrations. The avidities of several oligomeric mixtures were evaluated by means of a competitive binding assay using HEK293 cells engineered to overexpress the melanocortin 4 receptor. When based on total MSH4 concentrations, avidities were only minimally enhanced compared with a monovalent control. The lack of variation in the effect of ligands on probe binding is consistent with high off rates for MSH4 in both monovalent and oligomeric constructs relative to that of the competing probe.

Original languageEnglish (US)
Article number45546
Pages (from-to)3060-3065
Number of pages6
JournalTetrahedron Letters
Issue number23
StatePublished - Jul 3 2015


  • Competitive binding assay
  • Melanocortin 4 receptor
  • Multivalent ligand
  • Oligomerization
  • Time-resolved fluorescence

ASJC Scopus subject areas

  • Biochemistry
  • Drug Discovery
  • Organic Chemistry


Dive into the research topics of 'Synthesis and bioactivity of MSH4 oligomers prepared by an A2 + B2 strategy'. Together they form a unique fingerprint.

Cite this